Editorial

Metabolic agents and angina treatment

“…drugs that act directly by increasing the energy supply in cardiac cells are of use, whatever the causal mechanism involved, and as such are essential for the optimal treatment of ischemia. To protect myocardial cells from ischemia, energy supply needs to match energy demand. b-Blockers have a positive impact, reducing energy demand, while metabolic agents, such as trimetazidine, increase energy supply. That is why the use of an agent like trimetazidine fully complements b-blocker therapy.”(…)

Medicographia n°128

Metabolic agents in the contemporary treatment of angina